S&P 500   3,617.21 (-0.58%)
DOW   29,563.21 (-1.16%)
QQQ   299.07 (+0.02%)
AAPL   120.25 (+3.14%)
MSFT   212.85 (-1.11%)
FB   275.76 (-0.74%)
GOOGL   1,758.21 (-1.61%)
AMZN   3,167.34 (-0.88%)
TSLA   584.30 (-0.25%)
NVDA   531.54 (+0.21%)
BABA   264.49 (-4.34%)
CGC   29.01 (+0.03%)
GE   10.26 (-1.35%)
MU   64.41 (+0.28%)
AMD   91.95 (+5.46%)
T   28.79 (-0.83%)
NIO   51.84 (-4.00%)
F   9.11 (+0.22%)
ACB   11.85 (+13.18%)
NFLX   489.02 (-0.48%)
BA   211.91 (-2.12%)
GILD   59.84 (-0.32%)
DIS   147.92 (+0.54%)
S&P 500   3,617.21 (-0.58%)
DOW   29,563.21 (-1.16%)
QQQ   299.07 (+0.02%)
AAPL   120.25 (+3.14%)
MSFT   212.85 (-1.11%)
FB   275.76 (-0.74%)
GOOGL   1,758.21 (-1.61%)
AMZN   3,167.34 (-0.88%)
TSLA   584.30 (-0.25%)
NVDA   531.54 (+0.21%)
BABA   264.49 (-4.34%)
CGC   29.01 (+0.03%)
GE   10.26 (-1.35%)
MU   64.41 (+0.28%)
AMD   91.95 (+5.46%)
T   28.79 (-0.83%)
NIO   51.84 (-4.00%)
F   9.11 (+0.22%)
ACB   11.85 (+13.18%)
NFLX   489.02 (-0.48%)
BA   211.91 (-2.12%)
GILD   59.84 (-0.32%)
DIS   147.92 (+0.54%)
S&P 500   3,617.21 (-0.58%)
DOW   29,563.21 (-1.16%)
QQQ   299.07 (+0.02%)
AAPL   120.25 (+3.14%)
MSFT   212.85 (-1.11%)
FB   275.76 (-0.74%)
GOOGL   1,758.21 (-1.61%)
AMZN   3,167.34 (-0.88%)
TSLA   584.30 (-0.25%)
NVDA   531.54 (+0.21%)
BABA   264.49 (-4.34%)
CGC   29.01 (+0.03%)
GE   10.26 (-1.35%)
MU   64.41 (+0.28%)
AMD   91.95 (+5.46%)
T   28.79 (-0.83%)
NIO   51.84 (-4.00%)
F   9.11 (+0.22%)
ACB   11.85 (+13.18%)
NFLX   489.02 (-0.48%)
BA   211.91 (-2.12%)
GILD   59.84 (-0.32%)
DIS   147.92 (+0.54%)
S&P 500   3,617.21 (-0.58%)
DOW   29,563.21 (-1.16%)
QQQ   299.07 (+0.02%)
AAPL   120.25 (+3.14%)
MSFT   212.85 (-1.11%)
FB   275.76 (-0.74%)
GOOGL   1,758.21 (-1.61%)
AMZN   3,167.34 (-0.88%)
TSLA   584.30 (-0.25%)
NVDA   531.54 (+0.21%)
BABA   264.49 (-4.34%)
CGC   29.01 (+0.03%)
GE   10.26 (-1.35%)
MU   64.41 (+0.28%)
AMD   91.95 (+5.46%)
T   28.79 (-0.83%)
NIO   51.84 (-4.00%)
F   9.11 (+0.22%)
ACB   11.85 (+13.18%)
NFLX   489.02 (-0.48%)
BA   211.91 (-2.12%)
GILD   59.84 (-0.32%)
DIS   147.92 (+0.54%)
Log in
NASDAQ:EVFM

Evofem Biosciences Price Target, Predictions & Analyst Ratings

$2.26
-0.03 (-1.31 %)
(As of 11/30/2020 02:45 PM ET)
Add
Compare
Today's Range
$2.21
Now: $2.26
$2.29
50-Day Range
$2.15
MA: $2.49
$2.91
52-Week Range
$1.91
Now: $2.26
$7.50
Volume41,392 shs
Average Volume2.42 million shs
Market Capitalization$183.69 million
P/E RatioN/A
Dividend YieldN/A
Beta0.36

Analyst Ratings

Evofem Biosciences (NASDAQ:EVFM) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for Evofem Biosciences in the last 12 months. Their average twelve-month price target is $9.71, predicting that the stock has a possible upside of 329.84%. The high price target for EVFM is $25.00 and the low price target for EVFM is $3.00. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
EVFM Consensus Rating: BuyBuyBuyBuy
EVFM Consensus Rating Score: 2.862.862.833.00
EVFM Analyst Ratings: 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
EVFM Consensus Price Target: $9.71$9.71$10.50$12.75
EVFM Price Target Upside: 329.84% upside179.64% upside186.03% upside138.25% upside

Evofem Biosciences (NASDAQ:EVFM) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Evofem Biosciences (NASDAQ:EVFM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/1/2020Stifel NicolausInitiated CoverageBuy$5.00High
8/20/2020Morgan StanleyInitiated CoverageEqual Weight$3.00High
8/10/2020OppenheimerBoost Price TargetOutperform$18.00 ➝ $25.00Medium
6/9/2020HC WainwrightLower Price TargetBuy$11.00 ➝ $9.00Medium
6/8/2020Piper SandlerInitiated CoverageOverweight$11.00High
5/31/2020Royal Bank of CanadaReiterated RatingBuyLow
5/22/2020Cantor FitzgeraldReiterated RatingBuy$9.00N/A
6/20/2018Roth CapitalInitiated CoverageBuy$15.00High
(Data available from 11/30/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.